Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rick Greupink

Showing results (21-30 of 75) with videos related to

Pageof 8
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|January 28, 2006
The antiproliferative drug doxorubicin inhibits liver fibrosis in bile duct-ligated rats and can be selectively delivered to hepatic stellate cells in vivoRick Greupink, Hester I Bakker, Wilma Bouma, et al.
Molecular Pharmaceutics|April 24, 2014
Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3Elnaz Gozalpour, Rick Greupink, Heleen M Wortelboer, et al.
Archives of Toxicology|April 28, 2026
Comparison of ex vivo placenta perfusion and in vitro BeWo b30 cell models for assessing transfer of developmental and reproductive toxic compoundsDamian Roelofsen, Sandrine Spriggs, Beate Nicol, et al.
AIDS (London, England)|July 19, 2016
Substantially lowered dolutegravir exposure in a treatment-experienced perinatally HIV-1-infected pregnant womanStein Schalkwijk, Cornelia Feiterna-Sperling, Katharina Weizsäcker, et al.
Clinical Pharmacology and Therapeutics|December 24, 2019
Assessment of Maternal and Fetal Dolutegravir Exposure by Integrating Ex Vivo Placental Perfusion Data and Physiologically-Based Pharmacokinetic ModelingJolien J M Freriksen, Stein Schalkwijk, Angela P Colbers, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|February 8, 2022
Effects of tumor necrosis factor on undifferentiated and syncytialized placental choriocarcinoma BeWo cellsGaby A M Eliesen, Milou Fransen, Nina Kooijman, et al.
Biochemical Pharmacology|January 24, 2007
Pharmacokinetics of a hepatic stellate cell-targeted doxorubicin construct in bile duct-ligated ratsRick Greupink, Catharina Reker-Smit, Johannes H Proost, et al.
Clinical Pharmacokinetics|July 27, 2017
Prediction of Fetal Darunavir Exposure by Integrating Human Ex-Vivo Placental Transfer and Physiologically Based Pharmacokinetic ModelingStein Schalkwijk, Aaron O Buaben, Jolien J M Freriksen, et al.
Archives of Toxicology|April 10, 2017
Rat precision-cut liver slices predict drug-induced cholestatic injuryViktoriia Starokozhko, Rick Greupink, Petra van de Broek, et al.
Clinical Pharmacokinetics|June 20, 2018
Pharmacokinetics of HIV-Integrase Inhibitors During Pregnancy: Mechanisms, Clinical Implications and Knowledge GapsRuben van der Galiën, Rob Ter Heine, Rick Greupink, et al.
Pageof 8

Showing results (21-30 of 75) with videos related to

Sort By:
Pageof 8
The Journal of Pharmacology and Experimental Therapeutics|January 28, 2006
The antiproliferative drug doxorubicin inhibits liver fibrosis in bile duct-ligated rats and can be selectively delivered to hepatic stellate cells in vivoRick Greupink, Hester I Bakker, Wilma Bouma, et al.
Molecular Pharmaceutics|April 24, 2014
Interaction of digitalis-like compounds with liver uptake transporters NTCP, OATP1B1, and OATP1B3Elnaz Gozalpour, Rick Greupink, Heleen M Wortelboer, et al.
Archives of Toxicology|April 28, 2026
Comparison of ex vivo placenta perfusion and in vitro BeWo b30 cell models for assessing transfer of developmental and reproductive toxic compoundsDamian Roelofsen, Sandrine Spriggs, Beate Nicol, et al.
AIDS (London, England)|July 19, 2016
Substantially lowered dolutegravir exposure in a treatment-experienced perinatally HIV-1-infected pregnant womanStein Schalkwijk, Cornelia Feiterna-Sperling, Katharina Weizsäcker, et al.
Clinical Pharmacology and Therapeutics|December 24, 2019
Assessment of Maternal and Fetal Dolutegravir Exposure by Integrating Ex Vivo Placental Perfusion Data and Physiologically-Based Pharmacokinetic ModelingJolien J M Freriksen, Stein Schalkwijk, Angela P Colbers, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|February 8, 2022
Effects of tumor necrosis factor on undifferentiated and syncytialized placental choriocarcinoma BeWo cellsGaby A M Eliesen, Milou Fransen, Nina Kooijman, et al.
Biochemical Pharmacology|January 24, 2007
Pharmacokinetics of a hepatic stellate cell-targeted doxorubicin construct in bile duct-ligated ratsRick Greupink, Catharina Reker-Smit, Johannes H Proost, et al.
Clinical Pharmacokinetics|July 27, 2017
Prediction of Fetal Darunavir Exposure by Integrating Human Ex-Vivo Placental Transfer and Physiologically Based Pharmacokinetic ModelingStein Schalkwijk, Aaron O Buaben, Jolien J M Freriksen, et al.
Archives of Toxicology|April 10, 2017
Rat precision-cut liver slices predict drug-induced cholestatic injuryViktoriia Starokozhko, Rick Greupink, Petra van de Broek, et al.
Clinical Pharmacokinetics|June 20, 2018
Pharmacokinetics of HIV-Integrase Inhibitors During Pregnancy: Mechanisms, Clinical Implications and Knowledge GapsRuben van der Galiën, Rob Ter Heine, Rick Greupink, et al.
Pageof 8